Holen Sie sich die Stockscreener-App
1.15
6.48%
0.07
Schlusskurs vom Vortag:
$1.08
Offen:
$1.04
24-Stunden-Volumen:
35,936
Relative Volume:
10.51
Marktkapitalisierung:
$N/A
Einnahmen:
$14.86M
Nettoeinkommen (Verlust:
$-56.00M
KGV:
-0.2531
EPS:
-4.5442
Netto-Cashflow:
$-45.58M
1W Leistung:
+6.48%
1M Leistung:
+32.18%
6M Leistung:
+21.12%
1J Leistung:
-82.58%
1-Tages-Spanne:
$1.04
$1.15
1-Wochen-Bereich:
$1.04
$1.15
52-Wochen-Spanne:
$0.86
$1.15
Hookipa Pharma Inc Stock (HOOK) Company Profile
Firmenname
Hookipa Pharma Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare HOOK vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOOK
Hookipa Pharma Inc
|
1.15 | 0 | 14.86M | -56.00M | -45.58M | -4.5442 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Hookipa Pharma Inc Stock (HOOK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-20 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-11-15 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-12-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-11-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-08 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-03 | Eingeleitet | Truist | Buy |
| 2020-10-26 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-10-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2019-09-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-05-13 | Eingeleitet | BofA/Merrill | Buy |
| 2019-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Hookipa Pharma Inc Aktie (HOOK) Neueste Nachrichten
HOOKIPA Pharma Inc Stock: Areola Virus Vaccine Innovator Seeks Prophylactic Breakthrough with ISIN U - AD HOC NEWS
HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics - markets.businessinsider.com
NeoTrail Therapeutics, Inc. completed the acquisition of Oncology Assets from HOOKIPA Pharma Inc. (OTCPK : HOOK). - MarketScreener
Breakout Move: How does HOOKIPA Pharma Inc compare to its peers2026 Sector Review & Real-Time Volume Triggers - baoquankhu1.vn
New Highs: Will HOOKIPA Pharma Inc benefit from government policy2026 Historical Comparison & High Return Stock Watch Alerts - baoquankhu1.vn
HOOKIPA Pharma Inc stock faces renewed scrutiny after failed merger and pipeline updates in biotech - AD HOC NEWS
Aug Rallies: Can HOOKIPA Pharma Inc reach all time highs this yearStop Loss & Reliable Trade Execution Plans - baoquankhu1.vn
Gilead (GILD) to Acquire HOOK for $10 million - msn.com
HOOKIPA Pharma Stock: What Latest Pipeline Moves Mean for U.S. Investors - AD HOC NEWS
HOOKIPA Pharma (HOOK) Expected to Announce Earnings on Friday - Defense World
Risk Check: Will HOOKIPA Pharma Inc benefit from government policy2025 EndofYear Setup & Entry Point Confirmation Signals - baoquankhu1.vn
Why HOOKIPA Pharma Inc. stock remains on buy lists2025 Growth vs Value & AI Powered Market Entry Ideas - mfd.ru
How does HOOKIPA Pharma Inc. compare to its peersWeekly Trade Summary & Real-Time Stock Price Movement Reports - mfd.ru
Aug Outlook: What is the dividend yield of HOOKIPA Pharma Inc2025 Risk Factors & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Published on: 2026-02-12 12:26:37 - mfd.ru
Why retail investors pile into HOOKIPA Pharma Inc. stockIPO Watch & Capital Efficiency Focused Strategies - mfd.ru
HOOKIPA Pharma T0 Sell Oncology Assets HB-200 And HB-700 To NeoTrail Therapeutics - Nasdaq
HOOKIPA Pharma (HOOK) Divests Key Immuno-Oncology Assets - GuruFocus
HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics - markets.businessinsider.com
HOOKIPA Pharma Sells Oncology Assets To NeoTrail Therapeutics - citybiz
HOOKIPA Pharma Inc. Sells Immuno-Oncology Assets HB-200 and HB-700 to NeoTrail Therapeutics - Quiver Quantitative
Hookipa Pharma Announces Sale Of Oncology Assets To Neotrail Therapeutics - TradingView
Dip Buying: How does HOOKIPA Pharma Inc compare to its peersWeekly Earnings Recap & Growth Oriented Trading Recommendations - baoquankhu1.vn
Stock Analysis: Can HOOKIPA Pharma Inc deliver consistent EPS growthJuly 2025 Analyst Calls & Capital Efficiency Focused Ideas - baoquankhu1.vn
Growth Value: Will HOOKIPA Pharma Inc benefit from government policyTrade Volume Summary & Daily Oversold Bounce Ideas - baoquankhu1.vn
Will HOOKIPA Pharma Inc. stock benefit from commodity pricesMarket Performance Summary & Free Accurate Trade Setup Notifications - ulpravda.ru
Will HOOKIPA Pharma Inc. stock outperform growth indexesQuarterly Risk Review & High Conviction Buy Zone Alerts - Улправда
How risky is HOOKIPA Pharma Inc. stock nowQuarterly Profit Report & Long-Term Growth Portfolio Plans - Улправда
Why HOOKIPA Pharma Inc. stock remains resilientTrade Entry Report & AI Optimized Trade Strategies - Улправда
Is CEL SCI Corporation stock a contrarian buyPortfolio Performance Summary & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
Update Report: Will HOOKIPA Pharma Inc. stock outperform growth indexes2025 Momentum Check & Fast Momentum Entry Tips - Улправда
Will HOOKIPA Pharma Inc. stock maintain momentum in 2025Weekly Loss Report & Fast Momentum Stock Entry Tips - Улправда
Is HOOKIPA Pharma Inc. stock near bottom after declineJuly 2025 Rallies & Weekly Market Pulse Alerts - Улправда
Aug Sentiment: Why HOOKIPA Pharma Inc stock remains resilientJuly 2025 PostEarnings & Growth Focused Stock Reports - moha.gov.vn
Is HOOKIPA Pharma Inc. stock trading at a premium valuationInsider Buying & Reliable Breakout Forecasts - Newser
Why HOOKIPA Pharma Inc. stock is trending among retail tradersPortfolio Update Summary & AI Powered Trade Plan Recommendations - Newser
Gilead to buy certain Hookipa Pharma assets for up to $10M - MSN
HOOKIPA Pharma Inc Stock Analysis and ForecastMarket Volatility Update & Hedge Fund-Style Analysis Now Free - earlytimes.in
What drives HOOKIPA Pharma Inc stock priceVolume Weighted Average Price & Affordable Trading Strategies - earlytimes.in
Is HOOKIPA Pharma Inc. stock supported by strong cash flowsEarnings Beat & Target Return Focused Stock Picks - newser.com
Can HOOKIPA Pharma Inc. stock reach $100 price targetTrade Volume Report & Verified Entry Point Signals - newser.com
Why HOOKIPA Pharma Inc. stock appeals to dividend seekersMarket Volume Report & Safe Swing Trade Setups - newser.com
Will HOOKIPA Pharma Inc. stock deliver strong dividend growth2025 Technical Overview & Expert Verified Stock Movement Alerts - newser.com
Forecasting HOOKIPA Pharma Inc. price range with options dataWeekly Gains Report & Accurate Entry/Exit Alerts - newser.com
Finanzdaten der Hookipa Pharma Inc-Aktie (HOOK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.49%
1.47%
Kapitalisierung:
|
Volumen (24h):